★
Trade Filings
Managers Stocks Filings Superinvestors
Signals Institutional Buying Institutional Selling Insider Activity 13D & 13G Watch Sector Rotation
Tools Stock Screener Manager Screener Compare Managers Consensus Baskets All Research Tools Data API
Learn & AI Learn Ask the Data AI Agents
News ★ Saved
About About us Methodology Contact Disclaimer
Reader
DATA PLANS

Historical data downloads — coming with accounts.

API GATEWAY

Free read-only JSON access to the site's cached data.
Dark mode

🧭 Guided View
New to markets — prices, yields, YTD, market cap? We explain every term as you browse, in plain English. Same data, with the help built in.

⚡ Expert View
You already know the market. Just the data — clean, fast and compact, with no extra explanations. This is the default view.

Interface language
Security record · archived quarter

LLY

Eli Lilly and Company · Healthcare · Drug Manufacturers - General

1,233.5 -1.1% mkt cap $1.16T quote delayed (FMP) · as of Aug 25 22:08 UTC — separate from filing data below

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024
28Tracked holders
-1Δ holders
307.45MShares held
$239.60BReported value
+2New positions
−3Exits
Falling Conviction score 39/100 How these are computed → Explain this at the Research Desk →

Momentum inputs (comparable managers): holder breadth -3.4% · share flow -1.6% · net new positions -3.6% — formula
Broad distribution — falling shares and fewer holders

All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025

Ownership over time
QuarterHoldersΔSharesReported valueNewExits
Q2 2026 193 +4 671.92M $804.91B +6 −1
Q1 2026 191 -3 666.59M $613.20B +1 −5
Q4 2025 193 +2 707.04M $758.81B +3 —
Q3 2025 27 -3 329.88M $251.63B +2 −6
Q2 2025 28 -1 307.45M $239.60B +2 −3
Q1 2025 26 0 140.32M $115.83B +1 −1
Q4 2024 26 +1 145.00M $111.91B +3 −2
Q3 2024 24 +2 109.89M $97.29B +2 —
Q2 2024 22 — 112.43M $101.75B — —
Holder count
Who holds it · Q2 2025
#ManagerSharesΔ sharesValueTheir weightHeld
1 The Vanguard Group ✦ (passive) 80.41M — $62.68B 1.0% n/c 1 SEC ↗
2 The Vanguard Group ✦ (passive) 80.41M — $62.68B 1.0% n/c 1 SEC ↗
3 The Vanguard Group ✦ (passive) 80.41M — $62.68B 1.0% n/c 1 SEC ↗
4 The Vanguard Group ✦ (passive) 80.41M — $62.68B 1.0% n/c 1 SEC ↗
5 The Vanguard Group ✦ (passive) 80.41M — $62.68B 1.0% n/c 1 SEC ↗
6 The Vanguard Group ✦ (passive) 80.41M — $62.68B 1.0% n/c 1 SEC ↗
7 BlackRock ✦ (passive) 65.96M — $51.42B 1.0% n/c 1 SEC ↗
8 BlackRock ✦ (passive) 65.96M — $51.42B 1.0% n/c 1 SEC ↗
9 BlackRock ✦ (passive) 65.96M — $51.42B 1.0% n/c 1 SEC ↗
10 BlackRock ✦ (passive) 65.96M — $51.42B 1.0% n/c 1 SEC ↗
11 BlackRock ✦ (passive) 65.96M — $51.42B 1.0% n/c 1 SEC ↗
12 BlackRock ✦ (passive) 65.96M — $51.42B 1.0% n/c 1 SEC ↗
13 BlackRock ✦ (passive) 65.96M — $51.42B 1.0% n/c 1 SEC ↗
14 BlackRock ✦ (passive) 65.96M — $51.42B 1.0% n/c 1 SEC ↗
15 BlackRock ✦ (passive) 65.96M — $51.42B 1.0% n/c 1 SEC ↗
16 BlackRock ✦ (passive) 65.96M — $51.42B 1.0% n/c 1 SEC ↗
17 BlackRock ✦ (passive) 65.96M — $51.42B 1.0% n/c 1 SEC ↗
18 BlackRock ✦ (passive) 65.96M — $51.42B 1.0% n/c 1 SEC ↗
19 BlackRock ✦ (passive) 65.96M — $51.42B 1.0% n/c 1 SEC ↗
20 BlackRock ✦ (passive) 65.96M — $51.42B 1.0% n/c 1 SEC ↗
21 BlackRock ✦ (passive) 65.96M — $51.42B 1.0% n/c 1 SEC ↗
22 BlackRock ✦ (passive) 65.96M — $51.42B 1.0% n/c 1 SEC ↗
23 BlackRock ✦ (passive) 65.96M — $51.42B 1.0% n/c 1 SEC ↗
24 BlackRock ✦ (passive) 65.96M — $51.42B 1.0% n/c 1 SEC ↗
25 BlackRock ✦ (passive) 65.96M — $51.42B 1.0% n/c 1 SEC ↗
26 BlackRock ✦ (passive) 65.96M — $51.42B 1.0% n/c 1 SEC ↗
27 BlackRock ✦ (passive) 65.96M — $51.42B 1.0% n/c 1 SEC ↗
28 BlackRock ✦ (passive) 65.96M — $51.42B 1.0% n/c 1 SEC ↗
29 BlackRock ✦ (passive) 65.96M — $51.42B 1.0% n/c 1 SEC ↗
30 State Street Global Advisors ✦ (passive) 34.51M +0.2% $26.90B 1.0% ▲ Add 3 SEC ↗
31 Fidelity (FMR) ✦ 25.63M — $19.98B 1.1% n/c 1 SEC ↗
32 Fidelity (FMR) ✦ 25.63M — $19.98B 1.1% n/c 1 SEC ↗
33 Fidelity (FMR) ✦ 25.63M — $19.98B 1.1% n/c 1 SEC ↗
34 Fidelity (FMR) ✦ 25.63M — $19.98B 1.1% n/c 1 SEC ↗
35 Fidelity (FMR) ✦ 25.63M — $19.98B 1.1% n/c 1 SEC ↗
36 Fidelity (FMR) ✦ 25.63M — $19.98B 1.1% n/c 1 SEC ↗
37 Geode Capital Management ✦ (passive) 18.13M -2.1% $14.07B 1.0% ▼ Trim 5 SEC ↗
38 Geode Capital Management ✦ (passive) 18.13M -2.1% $14.07B 1.0% ▼ Trim 5 SEC ↗
39 Capital World Investors ✦ 17.63M -4.1% $13.75B 2.0% ▼ Trim 5 SEC ↗
40 T. Rowe Price ✦ 16.85M -12.0% $13.13B 1.5% ▼ Trim 5 SEC ↗
41 T. Rowe Price ✦ 16.85M -12.0% $13.13B 1.5% ▼ Trim 5 SEC ↗
42 Wellington Management ✦ 13.99M +10.1% $10.91B 2.0% ▲ Add 5 SEC ↗
43 Wellington Management ✦ 13.99M +10.1% $10.91B 2.0% ▲ Add 5 SEC ↗
44 Wellington Management ✦ 13.99M +10.1% $10.91B 2.0% ▲ Add 5 SEC ↗
45 Wellington Management ✦ 13.99M +10.1% $10.91B 2.0% ▲ Add 5 SEC ↗
46 Wellington Management ✦ 13.99M +10.1% $10.91B 2.0% ▲ Add 5 SEC ↗
47 Wellington Management ✦ 13.99M +10.1% $10.91B 2.0% ▲ Add 5 SEC ↗
48 Wellington Management ✦ 13.99M +10.1% $10.91B 2.0% ▲ Add 5 SEC ↗
49 Wellington Management ✦ 13.99M +10.1% $10.91B 2.0% ▲ Add 5 SEC ↗
50 Wellington Management ✦ 13.99M +10.1% $10.91B 2.0% ▲ Add 5 SEC ↗
51 PRIMECAP Management ✦ 12.15M -17.8% $9.48B 7.5% ▼ Trim 5 SEC ↗
52 Norges Bank ✦ (passive) 11.32M +3.0% $8.83B 1.1% ▲ Add 5 SEC ↗
53 Fisher Asset Management ✦ 4.30M -20.9% $3.35B 1.3% ▼ Trim 5 SEC ↗
54 Tiger Global Management ✦ 1.51M +13.2% $1.18B 3.5% ▲ Add 5 SEC ↗
55 Marshall Wace ✦ 931.73K +122.1% $726.31M 0.9% ▲ Add 5 SEC ↗
56 Marshall Wace ✦ 931.73K +122.1% $726.31M 0.9% ▲ Add 5 SEC ↗
57 Marshall Wace ✦ 931.73K +122.1% $726.31M 0.9% ▲ Add 5 SEC ↗
58 Citadel Advisors ✦ 853.25K +78.6% $665.14M 0.6% ▲ Add 5 SEC ↗
59 Citadel Advisors ✦ 853.25K +78.6% $665.14M 0.6% ▲ Add 5 SEC ↗
60 Adage Capital Partners ✦ 841.81K +13.5% $656.22M 1.1% ▲ Add 5 SEC ↗
61 Millennium Management ✦ 570.89K -16.2% $445.03M 0.4% ▼ Trim 5 SEC ↗
62 D. E. Shaw & Co. ✦ 528.13K -7.9% $411.69M 0.4% ▼ Trim 5 SEC ↗
63 D. E. Shaw & Co. ✦ 528.13K -7.9% $411.69M 0.4% ▼ Trim 5 SEC ↗
64 Viking Global Investors ✦ 416.92K New $325.00M 0.9% New 1 SEC ↗
65 AQR Capital Management ✦ 346.98K -38.9% $269.65M 0.2% ▼ Trim 5 SEC ↗
66 AQR Capital Management ✦ 346.98K -38.9% $269.65M 0.2% ▼ Trim 5 SEC ↗
67 AQR Capital Management ✦ 346.98K -38.9% $269.65M 0.2% ▼ Trim 5 SEC ↗
68 AQR Capital Management ✦ 346.98K -38.9% $269.65M 0.2% ▼ Trim 5 SEC ↗
69 AQR Capital Management ✦ 346.98K -38.9% $269.65M 0.2% ▼ Trim 5 SEC ↗
70 AQR Capital Management ✦ 346.98K -38.9% $269.65M 0.2% ▼ Trim 5 SEC ↗
71 Point72 Asset Management ✦ 188.51K +244.2% $146.95M 0.4% ▲ Add 2 SEC ↗
72 Coatue Management ✦ 117.42K -36.1% $91.53M 0.3% ▼ Trim 5 SEC ↗
73 Coatue Management ✦ 117.42K -36.1% $91.53M 0.3% ▼ Trim 5 SEC ↗
74 Duquesne Family Office ✦ 100.67K +6.2% $78.48M 2.0% ▲ Add 3 SEC ↗
75 Two Sigma Investments ✦ 73.75K +368.8% $57.49M 0.1% ▲ Add 5 SEC ↗
76 Dodge & Cox ✦ 44.96K -0.3% $35.05M 0.0% ▼ Trim 5 SEC ↗
77 GAMCO Investors ✦ 27.40K -8.9% $21.36M 0.2% ▼ Trim 5 SEC ↗
78 Gotham Asset Management ✦ 7.19K -4.8% $5.60M 0.0% ▼ Trim 5 SEC ↗
79 Harris Associates (Oakmark) ✦ 414 New $322,725 0.0% New 1 SEC ↗
80 Renaissance Technologies ✦ 261 -99.7% $204,662 0.0% ▼ Trim 4 SEC ↗

“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.

New buyers

Viking Global Investors $325.00M 0.9%
Harris Associates (Oakmark) $322,725 0.0%

Exited

Lone Pine Capital $455.76M was 4.0%
Arrowstreet Capital $34.20M was 0.0%
Bridgewater Associates $2.27M was 0.0%

Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 4,323 holders, 762.84M shares, $674.93B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.

Frequently co-owned

What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.

AVGO27shared holders META27shared holders MSFT27shared holders AMZN26shared holders GOOGL26shared holders
Insider transactions

Open-market purchases (P)

No open-market insider purchases in our coverage window.

Open-market sales (S)

Aug 17 Jonsson Patrik

Officer · 6.50K sh · $7.64M

Aug 10 Zakrowski Donald A

Officer · 2.00K sh · $2.37M

Aug 07 Hakim Anat

Officer · 5.00K sh · $5.95M

Awards, exercises and tax withholding are never counted as buys or sales here. Methodology

Beneficial ownership
Jul 23 SC 13G/A — LILLY ENDOWMENT INC

View original SEC filing ↗
In the news
Aug 24 FDA Clears Roche And Eli Lilly's Alzheimer's Blood Test ↗

The Food and Drug Administration has cleared a new blood test from Roche and Eli Lilly designed to help identify…

 Forbes
Aug 24 FDA Approves Alzheimer's Blood Test Developed by Roche and Eli Lilly ↗

The Food and Drug Administration cleared a blood test for identifying Alzheimer's disease symptoms, which was developed…

 WSJ
Aug 24 Roche, Eli Lilly's Alzheimer's blood test gets FDA clearance ↗

The U.S. Food and Drug Administration has cleared Roche and partner Eli Lilly's blood test to help ​identify signs of…

 Reuters
Aug 24 Eli Lilly Launches Foundayo Weight-Loss Pill in U.K. ↗

The once-daily pill was approved for patients with a body mass index of at least 30, or between 27 and 30 in the event…

 WSJ
Aug 23 Eli Lilly launches oral weight-loss pill Foundayo in UK ↗

Eli Lilly said on Monday it has launched its oral pill, ​Foundayo, in the UK for weight ‌management and type 2…

 Reuters
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR. Reporting period: Q2 2025 · Methodology · Get this via the API